• 1
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359362.
  • 2
    Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miya-mura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362364.
  • 3
    Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 1995; 15: 6469.
  • 4
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 18991905.
  • 5
    Resnick RH, Koff R. Hepatitis C–related hepatocellular carcinoma: prevalence and significance. Arch Intern Med 1993; 153: 16721677.
  • 6
    Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the Flavivirus envelope and NS1 proteins and the Pestivirus envelope glycoproteins. Virology 1991; 180: 842848.
  • 7
    Weiner AJ, Geysen HM, Christopherson C, Hall JE, Marson TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992; 89: 34683472.
  • 8
    Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135140.
  • 9
    Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Gen Virol 1992; 66: 32253229.
  • 10
    Sakamoto N, Enomoto N, Kurosaki M, Marumo F, Sato C. Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection. J Med Virol 1994; 42: 103108.
  • 11
    Yamaguchi K, Tanaka E, Higashi K, Kiyosawa K, Matsumoto A, Furuta S, Hasegawa A, et al. Adaptation of hepatitis C virus for persistent infection in patients with acute hepatitis. Gastroenterology 1994; 106: 13441348.
  • 12
    Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994; 106: 10721075.
  • 13
    Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 23482357.
  • 14
    Del Prete G, Maggi E, Romagnani S. Human Th1 and Th2 cells: functional properties, mechanisms of regulation, and role in disease. Lab Invest 1994; 70: 299306.
  • 15
    Street NE, Schumacher JH, Fong TAT, Bass H, Fiorentino DF, Leverah JA, Mosmann TR. Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J Immunol 1990; 144: 16291639.
  • 16
    Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227257.
  • 17
    Tsai SL, Chen PJ, Hwang LH, Kao JH, Huang JH, Chang TH, Chen DS. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection. J Hepatol 1994; 21: 403411.
  • 18
    Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178: 1725.
  • 19
    Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloon BR, Modlin RL. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277279.
  • 20
    Sieling PA, Abrams JS, Yamamura M, Salgame P, Bloom BR, Rea TH, Modlin RL. Immunosuppressive roles for IL-10 and IL-4 in human infection: in vitro modulation of T cell responses in leprosy. J Immunol 1993; 150: 55015510.
  • 21
    Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992; 10: 385409.
  • 22
    Gazzinelli RT, Makino M, Chattopadhyay SK, Snapper CM, Sher A, Hugin AW, Morse HC. CD4+ Subset regulation in viral infection: preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol 1992; 148: 182188.
  • 23
    Kanagawa O, Vaupel BA, Gayama S, Koehler G, Kopf M. Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 1993; 262: 240242.
  • 24
    Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138144.
  • 25
    Yeh CT, Han CM, Lo SY, Ou JH, Fan KD, Sheen IS, Chu CM, et al. Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by Western blot (immunoblot) using a recombinant HCV core protein fragment. J Clin Microbiol 1994; 32: 22352241.
  • 26
    Liaw YF, Tsai SL, Chang JJ, Sheen IS, Chien RN, Lin DY, Chu CM. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994; 106: 10481053.
  • 27
    Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: applications to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673679.
  • 28
    Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570583.
  • 29
    Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL, et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104: 580587.
  • 30
    Erard F, Wild MT, Garcia-Sanz JA, Le Gros GG. Switch of CD8 T to noncytolytic CD8CD4 cells that make TH2 cytokines and help B cells. Science 1993; 260: 18021805.
  • 31
    Llorente L, Richaud-Patin Y, Flor R, Alcocer-Varela J, Wijdenes J, Morel-Fourrier B, Galanaud P, et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 1994; 37: 16471655.
  • 32
    Liaw YF, Lee CS, Tsai SL, Liaw BW, Chen TC, Sheen IS, Chu CM. T-cell–mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995; 22: 13681373.
  • 33
    Waldmann TA, Davis MM, Bongiovanni KF, Korsmeyer SJ. Rearrangements of genes for the antigen receptor on T-cells as markers of lineage and clonality inhuman lymphoid neoplasms. N Engl J Med 1985; 313: 776783.
  • 34
    Ferrari C, Valli A, Galati L, Penna A, Scaccglia P, Giuberti T, Schianchi C, et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. HEPATOLOGY 1994; 19: 286295.
  • 35
    Hoffmann RM, Diepolder HM, Zachoval R, Zwiebel FM, Jung MC, Scholz S, Nitschko H, et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995; 21: 632638.
  • 36
    Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, Jung MC, Eichenlaub D, et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346: 10061007.
  • 37
    Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the antiviral cell-mediated immune response. J Clin Invest 1996; 98: 706714.
  • 38
    Del Prete GF, De Carli M, Mastromanro C, Macchia D, Biagiotti R, Ricci M, Romagnani S. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991; 88: 346350.
  • 39
    Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994; 330: 535538.
  • 40
    Inoue M, Kakumu S, Yoshioka K, Tsutsumi Y, Wakita T, Arao M. Hepatitis B core antigen-specific IFN-y production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J Immunol 1989; 142: 40064011.
  • 41
    Ferrari C, Mondelli MU, Penna A, Fiaccadori F, Chisari FV. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein specific helper T cell lines. J Immunol 1987; 139: 539544.
  • 42
    Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR. The serology of chronic hepatitis B infection revisited. J Clin Invest 1993; 91: 25862595.
  • 43
    Barnaba V, Franco A, Paroli M, Benvenuto R, De Petrillo G, Burgio VL, Santilio I, et al. Selective expansion of cytotoxic T lymphocytes with a CD4+ CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus. J Immunol 1994; 152: 30743087.
  • 44
    Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995; 15: 4163.
  • 45
    Peano G, Menardi G, Ponzetto A, Fenoglio LM. HLA-DR5 antigen: a genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 1994; 154: 27332736.
  • 46
    Gilles PN, Guerrette DL, Ulevitch RJ, Schreiber RD, Chisari FV. HBsAg retention sensitizes the hepatocyte to injury by physiological concentration of interferon-γ. Hepatology 1992; 16: 655663.
  • 47
    Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M, Yamamura K-I. Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver. Proc Natl Acad Sci USA 1994; 91: 614618.
  • 48
    Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241251.
  • 49
    Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang SN, et al. Mechanisms of class I restricted immunopathology: a transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178: 15411554.
  • 50
    Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-y –activated macrophages. J Immunol 1992; 148: 17921796.
  • 51
    Tanaka T, Hu-Li J, Seder RA, de St Groth BF, Paul WE. Interleukin 4 suppresses interleukin 2 and interferon y production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci U S A 1993; 90: 59145918.
  • 52
    Tsai SL, Yeh CT, Liaw YF, Huang JH, Kuo GC. Rapid emergence of naturally occurring hepatitis C virus (HCV) variants antagonizing cytotoxic T lymphocyte activity in acute HCV infection with chronic evolution [Abstract C68]. Presented at the 3rd International Meeting on Hepatitis C Virus and Related Viruses (Molecular Virology and Pathogenesis): Aug. 28-September 3, 1995, Gold Coast, Australia.
  • 53
    Wright TL, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, et al. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991; 115: 111112.
  • 54
    Féray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, Bismuth H, et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993; 104: 549555.
  • 55
    Liang TJ, Jeffers L, Reddy RK, Silva MO, Cheinquer H, Findor A, de Medina M, et al. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology 1993; 104: 556562.
  • 56
    Hoofnagle JH, Carithers Jr. RL, Shapiro C, Ascher N. Fulminant hepatic failure: summary of workshop. Hepatology 1995; 21: 240266.
  • 57
    Wang JT, Wang TH, Lin JT, Sheu JC, Sung JL, Chen DS. Hepatitis C virus in a prospective study of posttransfusion non-A, non-B hepatitis in Taiwan. J Med Virol 1990; 32: 8386.
  • 58
    Alberti A, Morsica G, Chemello L, Cavalletto D, Noventa F, Pontisso P, Ruol A. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992; 340: 697698.
  • 59
    Bhandari BN, Kim M, Ferrell L, Bacchetti P, Wright TL. Serum hepatitis C virus (HCV) levels and alanine transaminase (ALT) do not correlate with liver histopathology [Abstract]. Gastroenterology 1994; 106: A866.
  • 60
    Mishiro S, Hoshi Y, Takeda K, Yoshitawa A, Gotanda T, Takahashi K, Akahane Y, et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 1990; 336: 14001403.
  • 61
    Pawlotsky JM, Ben Hayia M, André C, Voisin MC, Intrator L, Roudot-Thoraval F, DeForges L, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841848.
  • 62
    Koskinas J, McFarlane BM, Nouri-Aria KT, Tibbs CJ, Mizokami M, Donaldson PT, McFarlane IG, et al. Cellular and humoral immune reactions against autoantigens and hepatitis C viral antigens in chronic hepatitis C. Gastroenterology 1994; 107: 14361442.
  • 63
    Löhr HF, Gerken G, Michel G, Braun HB, Zum Büschenfelde KHM. In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C. Gastroenterology 1994; 107: 14431448.
  • 64
    Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Yahia MB, André C, Voisin MC, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169173.